TI
TBPH icon

Trexquant Investment’s Theravance Biopharma TBPH Stock Holding History

Trexquant Investment’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.34M Buy
205,784
+23,294
+13% +$412K 0.02% 812
2025
Q4 		$3.41M Buy
182,490
+37,957
+26% +$630K 0.03% 768
2025
Q3 		$2.11M Sell
144,533
-12,397
-8% -$157K 0.02% 888
2025
Q2 		$1.73M Sell
156,930
-8,494
-5% -$82.6K 0.02% 931
2025
Q1 		$1.48M Buy
165,424
+14,341
+9% +$133K 0.02% 970
2024
Q4 		$1.42M Buy
151,083
+50,826
+51% +$462K 0.02% 983
2024
Q3 		$808K Buy
100,257
+66,735
+199% +$578K 0.01% 1110
2024
Q2 		$284K Buy
+33,522
New +$303K ﹤0.01% 1374
2023
Q1 		– Sell
-18,705
Closed -$210K – 1763
2022
Q4 		$210K Buy
+18,705
New +$197K 0.01% 1228
2022
Q1 		– Sell
-20,729
Closed -$229K – 1719
2021
Q4 		$229K Buy
+20,729
New +$181K 0.01% 1071
2020
Q4 		– Sell
-13,167
Closed -$195K – 1473
2020
Q3 		$195K Buy
13,167
+2,041
+18% +$38.2K 0.01% 1085
2020
Q2 		$234K Buy
+11,126
New +$286K 0.02% 990
2016
Q4 		– Sell
-5,995
Closed -$217K – 1127
2016
Q3 		$217K Sell
5,995
-6,061
-50% -$169K 0.05% 606
2016
Q2 		$274K Buy
+12,056
New +$260K 0.04% 689
2015
Q4 		– Sell
-55,000
Closed -$604K – 1251
2015
Q3 		$604K Buy
+55,000
New +$700K 0.05% 645

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's TBPH Position: Q1 2026 in Review

Trexquant Investment increased its Theravance Biopharma (TBPH) stake by 13% in Q1 2026, buying an estimated $412K and bringing the position to 205,784 shares worth $3.34M. The position accounts for 0.02% of the portfolio, ranked #812.

Trexquant Investment first reported a position in TBPH in Q3 2015 and has held it in 15 quarters since. The position peaked at $3.41M in Q4 2025. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Trexquant Investment held 205,784 shares of Theravance Biopharma worth $3.34M as of Q1 2026.
  • Trexquant Investment bought 23,294 Theravance Biopharma shares in Q1 2026, an estimated $412K.
  • Theravance Biopharma made up 0.02% of Trexquant Investment's portfolio in Q1 2026, its #812 holding.
  • Trexquant Investment first reported a position in Theravance Biopharma in Q3 2015 and has held it in 15 quarters since.
  • Trexquant Investment's Theravance Biopharma position peaked at $3.41M in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.